Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Coherus Biosciences

Coherus Biosciences reported $8K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Akebia Therapeutics AKBA:US USD 2K 0
Alnylam Pharmaceuticals ALNY:US USD 1.24M 3K
Amarin AMRN:US USD 301.28M 2.28M
Baxter International BAX:US USD 683M 0
BioMarin Pharmaceutical BMRN:US USD 188K 2K
Bluebird Bio BLUE:US USD 1.06M 234K
Coherus Biosciences CHRS:US USD 8K 0
Eli Lilly LLY:US USD 593.5M 600K
Endo International ENDP:US USD 67K 0
Fujifilm 4901:JP JPY 40.36B 0
Horizon Pharma HZNP:US USD 23K 0
Ironwood Pharmaceuticals IRWD:US USD 155K 1000
Myriad Genetics MYGN:US USD 800K 0
Pacira PCRX:US USD 46K 0
Perrigo PRGO:US USD 6.91B 25.9M
PTC Therapeutics PTCT:US USD 73K 1000
Revance Therapeutics RVNC:US USD 84K 2K
Sarepta Therapeutics SRPT:US USD 9K 0
Teva Pharmaceutical Industries Ltd TEVA:IT USD 57M 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
Xencor XNCR:US USD 605K 4K
Zoetis ZTS:US USD 5M 0